Exhibit 99.1
Metamaterial Inc.
Interim condensed consolidated financial statements (unaudited)
For the three months ended March 31, 2021, and 2020
Metamaterial Inc.
Interim condensed consolidated statements of financial position (unaudited)
[expressed in Canadian dollars]
As at March 31, 2021
| | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | | 15,187,356 | | | | 1,776,983 | |
Restricted cash [note 9] | | | 1,000,000 | | | | — | |
Grants receivable | | | 378,058 | | | | 417,442 | |
Other receivables | | | 175,074 | | | | 50,330 | |
Due from related party [note 4] | | | 61,199 | | | | — | |
Inventory | | | 429,026 | | | | 589,977 | |
Prepaid expenses | | | 396,580 | | | | 436,909 | |
HST receivable | | | 171,201 | | | | 196,526 | |
Total current assets | | | 17,798,494 | | | | 3,468,167 | |
Intangible assets, net | | | 5,657,677 | | | | 5,699,626 | |
Property and equipment, net [note 5] | | | 4,954,788 | | | | 3,515,523 | |
Right-of-use assets [note 16] | | | 1,554,995 | | | | 337,441 | |
Total non-current assets | | | 12,167,460 | | | | 9,552,590 | |
| | | 29,965,954 | | | | 13,020,757 | |
| | | | | | | | |
Liabilities and shareholders’ deficiency | | | | | | | | |
Current liabilities | | | | | | | | |
Trade and other payables | | | 3,787,844 | | | | 3,743,783 | |
Due to related party [note 4] | | | — | | | | 312,528 | |
Current portion of long-term debt [note 9] | | | 1,185,756 | | | | 369,921 | |
Current portion of deferred revenue [note 15] | | | 2,442,747 | | | | 1,578,676 | |
Current portion of deferred government assistance | | | 1,156,802 | | | | 992,560 | |
Secured convertible debentures [note 7] | | | — | | | | 7,060,493 | |
Unsecured convertible promissory notes [note 6] | | | 13,307,966 | | | | 1,531,960 | |
Current portion of lease liabilities [note 16] | | | 286,279 | | | | 192,001 | |
Total current liabilities | | | 22,167,394 | | | | 15,781,922 | |
Deferred revenue [note 15] | | | 875,868 | | | | 1,023,835 | |
Deferred government assistance | | | 140,866 | | | | 186,536 | |
Deferred tax liability | | | 347,865 | | | | 404,947 | |
Unsecured convertible debentures [note 8] | | | — | | | | 2,324,085 | |
Funding obligation | | | 1,026,686 | | | | 989,128 | |
Lease liabilities [note 16] | | | 1,373,733 | | | | 152,506 | |
Long-term debt [note 9] | | | 3,755,862 | | | | 3,493,029 | |
Total non-current liabilities | | | 7,520,880 | | | | 8,574,066 | |
Total liabilities | | | 29,688,274 | | | | 24,355,988 | |
| | | | | | | | |
Shareholders’ deficiency | | | | | | | | |
Common shares [note 10] | | | 100,351,896 | | | | 34,248,734 | |
Contributed surplus [note 11] | | | 6,305,182 | | | | 5,804,292 | |
Warrants [note 10] | | | 535,442 | | | | 565,446 | |
Accumulated other comprehensive income | | | 252,788 | | | | 134,648 | |
Deficit | | | (107,167,628 | ) | | | (52,088,351 | ) |
Total shareholders’ equity (deficiency) | | | 277,680 | | | | (11,335,231 | ) |
| | | 29,965,954 | | | | 13,020,757 | |
| | | | | | | | |
Going concern [note 2] | | | | | | | | |
Commitments [note 18] | | | | | | | | |
Subsequent events [note 19] | | | | | | | | |
See accompanying notes | | | | | | | | |
| | | | | | | | |
On behalf of the Board: | | | | | | | | |
| | | | | | | | |
| | | Director | | | | Director | |
Metamaterial Inc.
Interim condensed consolidated statements of loss and comprehensive loss (unaudited)
[expressed in Canadian dollars]
| | Three months ended March 31 | |
| | 2021 | | | 2020 | |
| | $ | | | $ | |
| | | | | | |
Product sales | | | 27,955 | | | | 2,615 | |
Development revenue | | | 728,189 | | | | 594,960 | |
Revenue | | | 756,144 | | | | 597,575 | |
Cost of goods sold | | | 508 | | | | 1,121 | |
Gross Profit | | | 755,636 | | | | 596,454 | |
| | | | | | | | |
Expenses (income) | | | | | | | | |
Salaries and benefits | | | 1,388,842 | | | | 1,199,037 | |
Depreciation and amortization | | | 828,360 | | | | 878,902 | |
Impairment expense [note 7] | | | — | | | | — | |
Travel and entertainment | | | 4,516 | | | | 72,237 | |
Other expenses | | | 339,235 | | | | 137,528 | |
Listing expenses | | | — | | | | 3,353,512 | |
Stock exchange fees | | | 4,150 | | | | — | |
Rent and utilities | | | 81,017 | | | | 116,212 | |
Finance income [note 17] | | | (806 | ) | | | (16,350 | ) |
Finance costs [note 17] | | | 672,627 | | | | 263,674 | |
Consulting | | | 451,776 | | | | 216,959 | |
Investor relations | | | 128,761 | | | | 19,506 | |
Research and development | | | 709,111 | | | | 118,458 | |
Professional fees | | | 1,062,802 | | | | 271,574 | |
Share-based compensation expense [note 11] | | | 541,151 | | | | 450,028 | |
Unrealized gain on FVTPL liabilities [notes 6,7 and 8] | | | (250,456 | ) | | | (335,259 | ) |
Realized loss on FVTPL liabilities [notes 6,7 and 8] | | | 50,067,114 | | | | 128,653 | |
Technology license fees [note 4] | | | 525 | | | | 13,057 | |
Realized foreign currency exchange loss | | | 124,475 | | | | 62,163 | |
Unrealized foreign currency exchange loss (gain) | | | 61,811 | | | | (850,982 | ) |
Government assistance | | | (323,074 | ) | | | (45,671 | ) |
Other income | | | (400 | ) | | | — | |
| | | 55,891,537 | | | | 6,053,238 | |
Net loss before tax | | | (55,135,901 | ) | | | (5,456,784 | ) |
Income tax recovery | | | 56,624 | | | | 64,429 | |
Net loss for the period | | | (55,079,277 | ) | | | (5,392,355 | ) |
| | | | | | | | |
Other comprehensive income, net of income taxes | | | | | | | | |
Items that may be subsequently reclassified to income: | | | | | | | | |
Unrealized foreign currency translation adjustment | | | 118,140 | | | | (634,668 | ) |
Comprehensive loss for the period | | | (54,961,137 | ) | | | (6,027,023 | ) |
| | | | | | | | |
Basic and diluted loss per share | | $ | (0.60 | ) | | $ | (0.12 | ) |
Weighted average number of shares outstanding - basic and diluted | | | 91,277,328 | | | | 46,587,115 | |
See accompanying notes
Metamaterial Inc.
Interim condensed consolidated statements of changes in shareholders’ equity (unaudited)
[expressed in Canadian dollars]
Three months ended March 31
| | | | | | | | | | | | | | | | | Accumulated | | | Total | |
| | | | | | | | | | | | | | | | | other | | | Shareholders’ | |
| | Common | | | Preferred | | | Contributed | | | | | | | | | comprehensive | | | Equity | |
| | shares | | | shares | | | surplus | | | Warrants | | | Deficit | | | income/(loss) | | | (deficiency) | |
| | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | |
Balance, January 1, 2021 | | | 34,248,734 | | | | — | | | | 5,804,292 | | | | 565,446 | | | | (52,088,351 | ) | | | 134,648 | | | | (11,335,231 | ) |
Net loss | | | — | | | | — | | | | — | | | | — | | | | (55,079,277 | ) | | | — | | | | (55,079,277 | ) |
Other comprehensive income | | | — | | | | — | | | | — | | | | — | | | | — | | | | 118,140 | | | | 118,140 | |
Conversion of promissory notes [notes 6 and 10] | | | 30,005,734 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 30,005,734 | |
Conversion of secured debentures [notes 7 and 10] | | | 27,938,233 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 27,938,233 | |
Conversion of unsecured debentures [notes 8 and 10] | | | 7,318,001 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 7,318,001 | |
Conversion of long-term debt [notes 9 and 10] | | | 277,148 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 277,148 | |
Conversion of due to related party [notes 4 and 10] | | | 281,465 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 281,465 | |
Exercise of stock options [notes 10 and 11] | | | 101,920 | | | | — | | | | (40,261 | ) | | | — | | | | — | | | | — | | | | 61,659 | |
Exercise of warrants [note 10] | | | 56,240 | | | | — | | | | — | | | | (16,193 | ) | | | — | | | | | | | | 40,047 | |
Exercise of broker warrants [note 10] | | | 34,421 | | | | — | | | | — | | | | (13,811 | ) | | | — | | | | — | | | | 20,610 | |
Share-based compensation [notes 10 and 11] | | | 90,000 | | | | — | | | | 541,151 | | | | — | | | | — | | | | — | | | | 631,151 | |
Balance, March 31, 2021 | | | 100,351,896 | | | | — | | | | 6,305,182 | | | | 535,442 | | | | (107,167,628 | ) | | | 252,788 | | | | 277,680 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance, January 1, 2020 | | | 7,598,670 | | | | 12,748,100 | | | | 3,753,211 | | | | 175,095 | | | | (32,282,011 | ) | | | (159,512 | ) | | | (8,166,447 | ) |
Net loss | | | — | | | | — | | | | — | | | | — | | | | (5,392,355 | ) | | | — | | | | (5,392,355 | ) |
Other comprehensive loss | | | — | | | | — | | | | — | | | | — | | | | — | | | | (634,668 | ) | | | (634,668 | ) |
Issuance of common shares [note 10] | | | 875,612 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 875,612 | |
Issuance of warrants [note 10] | | | (204,054 | ) | | | — | | | | — | | | | 204,054 | | | | — | | | | — | | | | — | |
Issuance of broker warrants [note 10] | | | (21,962 | ) | | | — | | | | — | | | | 21,962 | | | | — | | | | — | | | | — | |
Share issuance cost [note 10] | | | (61,342 | ) | | | — | | | | — | | | | — | | | | — | | | | — | | | | (61,342 | ) |
Conversion of deferred share units [note 10] | | | 55,100 | | | | — | | | | (55,100 | ) | | | — | | | | — | | | | — | | | | — | |
Conversion of promissory notes [note 10] | | | 5,948,003 | | | | — | | | | — | | | | — | | | | — | | | | — | | | | 5,948,003 | |
Conversion of preferred shares [note 10] | | | 12,748,100 | | | | (12,748,100 | ) | | | — | | | | — | | | | — | | | | — | | | | — | |
Fair value of deemed issuance to CPM [note 10] | | | 7,258,276 | | | | — | | | | 285,157 | | | | — | | | | — | | | | — | | | | 7,543,433 | |
Share-based compensation [notes 10 and 11] | | | 100,000 | | | | — | | | | 265,062 | | | | 170,444 | | | | — | | | | — | | | | 535,506 | |
Balance, March 31, 2020 | | | 34,296,403 | | | | — | | | | 4,248,330 | | | | 571,555 | | | | (37,674,366 | ) | | | (794,180 | ) | | | 647,742 | |
Metamaterial Inc.
Interim condensed consolidated statements of cash flows (unaudited)
[expressed in Canadian dollars]
| | March 31 | | | March 31 | |
Three months ended March 31 | | 2021 | | | 2020 | |
| | $ | | | $ | |
| | | | | | |
Operating activities | | | | | | | | |
Net loss for the period | | | (55,079,277 | ) | | | (5,392,355 | ) |
Add (deduct) items not affecting cash: | | | | | | | | |
Non-cash finance income [note 17] | | | — | | | | (16,085 | ) |
Non-cash finance costs [note 17] | | | 557,236 | | | | 225,922 | |
Deferred income tax recovery | | | (56,624 | ) | | | (64,429 | ) |
Depreciation and amortization | | | 828,360 | | | | 878,902 | |
Unrealized foreign currency exchange loss | | | 143,649 | | | | (900,091 | ) |
Listing expenses | | | — | | | | 3,353,512 | |
Unrealized gain on FVTPL liabilities [notes 6,7 and 8] | | | (250,455 | ) | | | (335,259 | ) |
Realized loss on FVTPL liabilities [notes 6,7 and 8] | | | 50,067,114 | | | | 128,653 | |
Change in deferred revenue [note 15] | | | 717,404 | | | | (104,305 | ) |
Change in deferred government assistance | | | (158,831 | ) | | | 144,196 | |
Share-based compensation expense [note 11] | | | 541,151 | | | | 450,028 | |
Non-cash consulting | | | — | | | | 30,000 | |
Net change in non-cash working capital items [note 13] | | | (182,265 | ) | | | (2,110,991 | ) |
Cash used in operating activities | | | (2,872,538 | ) | | | (3,712,302 | ) |
| | | | | | | | |
Investing activities | | | | | | | | |
Additions to intangible assets | | | (52,902 | ) | | | (69,086 | ) |
Additions to property and equipment [note 5] | | | (1,801,618 | ) | | | (309,851 | ) |
Increase in restricted cash [note 9] | | | (1,000,000 | ) | | | — | |
Reverse takeover, net cash | | | — | | | | 4,174,979 | |
Cash (used in) provided by investing activities | | | (2,854,520 | ) | | | 3,796,042 | |
| | | | | | | | |
Financing activities | | | | | | | | |
Proceeds from long-term debt [note 9] | | | 1,390,000 | | | | 50,079 | |
Repayment of long-term debt [note 9] | | | (17,856 | ) | | | (25,658 | ) |
Proceeds from unsecured convertible promissory notes [note 6] | | | 17,704,800 | | | | — | |
Proceeds from exercise of stock options [note 10] | | | 61,659 | | | | — | |
Proceeds from exercise of warrants [note 10] | | | 60,657 | | | | — | |
Net proceeds from units [note 10] | | | — | | | | 814,270 | |
Proceeds from unsecured convertible debentures [note 8] | | | — | | | | 450,000 | |
Payment of lease liabilities [note 16] | | | (57,620 | ) | | | (25,988 | ) |
Cash provided by financing activities | | | 19,141,640 | | | | 1,262,703 | |
| | | | | | | | |
| | | | | | | | |
Net increase in cash and cash equivalents | | | 13,414,582 | | | | 1,346,443 | |
Cash and cash equivalents, beginning of the period | | | 1,776,983 | | | | 528,691 | |
Effects of exchange rate changes on cash and cash equivalents | | | (4,209 | ) | | | 10,768 | |
Cash and cash equivalents, end of the period | | | 15,187,356 | | | | 1,885,902 | |
| | | | | | | | |
Supplemental cash flow information | | | | | | | | |
Interest on debt paid | | | 81,818 | | | | 20,335 | |
See accompanying notes
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
1. Corporate information
Metamaterial Inc. [the “Company” or “META”] is a smart materials and photonics company specializing in metamaterial research and products, nanofabrication, and computational electromagnetics. The Company’s registered office is located at 1 Research Drive, Halifax, Nova Scotia, Canada.
On March 5, 2020, Metamaterial Inc. (formerly known as Continental Precious Minerals Inc., “CPM”) and Metamaterial Technologies Inc. (“MTI”) completed a business combination by way of a three-cornered amalgamation pursuant to which MTI amalgamated with a subsidiary of CPM, known as Continental Precious Minerals Subco Inc. (“CPM Subco”), to become “Metacontinental Inc.” (the “RTO”). The RTO was completed pursuant to the terms and conditions of an amalgamation agreement dated August 16, 2019 between CPM, MTI and CPM Subco, as amended March 4, 2020. Following the completion of the RTO, Metacontinental Inc. is carrying on the business of the former MTI, as a wholly-owned subsidiary of the CPM. In connection with the RTO, CPM changed its name effective March 2, 2020 from Continental Precious Minerals Inc. to Metamaterial Inc. (“META” or “Resulting Issuer”). The common shares of CPM were delisted from the TSX Venture Exchange on March 4, 2020 and were posted for trading on the Canadian Securities Exchange (“CSE”) on March 9, 2020 under the symbol “MMAT”.
On December 14, 2020, the Company executed an Arrangement Agreement with Torchlight Energy Resources, Inc. (“Torchlight”). The agreement calls for Torchlight and Metamaterial to be combined such that at closing, the former equity holders of Torchlight would own approximately 25% of the combined company with the former equity holders of Metamaterial owning the remaining approximately 75% of the combined company. Agreement included a condition that Torchlight must raise gross proceeds of at least $10 million through the issuance of common stock or securities convertible into or exercisable for common stock, less USD $1 million of loans Torchlight has made to Metamaterial. The closing of the transaction is subject to the satisfaction or waiver of customary closing conditions, including approvals by NASDAQ and the Canadian Securities Exchange (“CSE”), Canadian court approval, and approval by the shareholders of both companies.
On February 10, 2021, Torchlight announced it’s success in raising US $27.6 million from public offering and has loaned the Company US$10 million in form of a unsecured convertible promissory note.
On March 18, 2021, the Company obtained final order from Ontario Superior Court of Justice approving the plan of arrangement. The Business Combination Transaction was previously approved by the Company’s securityholders at the annual general and special meeting of securityholders held on March 12, 2021. On May 7, 2021, Torchlight has filed a definitive proxy statement for its special meeting of the stockholders on June 11, 2021.
During March 2020, the COVID-19 outbreak was declared a pandemic by the World Health Organization. This has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. In response to this, the Company’s management implemented a Work-From-Home policy for management and non-engineering employees in all three locations for the remaining period of 2020 and partially through 2021. Although the Company’s supply chain has slowed down, the Company is currently able to maintain inventory of long lead items and is working with its suppliers to optimize future supply orders. Alameda County in the State of California, where the Company’s wholly owned subsidiary operates, went on lockdown and it has been declared a “major disaster” area. In March 2021, the county moved from purple tier 1 (substantial spread of virus) to orange tier (moderate level).
These unaudited interim condensed consolidated financial statements were authorized for issue in accordance with a resolution of the Company’s Board of Directors on May 31, 2021.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
2. Basis of presentation
Statement of Compliance
The unaudited interim condensed consolidated financial statements for the three months ended March 31, 2021, have been prepared in accordance with IAS 34 Interim Financial Reporting (“IAS 34”).
The unaudited interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Company’s annual audited consolidated financial statements for the year ended December 31, 2020.
Going Concern
These unaudited interim condensed consolidated financial statements have been prepared on the basis of International Financial Reporting Standards (“IFRS”) applicable to a going concern, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As of March 31, 2021, there are material uncertainties that casts substantial doubt about the appropriateness of a going concern assumption, as the Company incurred a net loss of $55,079,277 for the three months ended March 31, 2021, negative cash flow from operations of $2,872,538, and had a deficit of $107,167,628 as at March 31, 2021.
During the three months ended March 31, 2021, the Company has drawn the remaining balance of $5,000,000 under a $5,500,000 commitment letter (the “Bridge Loan”) with a shareholder. Further and pursuant to the Arrangement Agreement with Torchlight Energy Resources Inc., a NASDAQ listed entity, for a business combination in 2020, Torchlight was successful in raising additional equity funds and consequently has provided US $10,000,000 of financing to the Company through the issuance of an unsecured convertible promissory note. In addition, the company secured a long-term debt with ACOA for $390,000. Furthermore, the Company converted unsecured convertible promissory notes issued pursuant to the Bridge Loan of $5,526,082, unsecured convertible debentures of $1,936,984, long-term debt of $261,735, and due to related parties of $367,944 into common shares as well as forced conversion of secured convertible debentures of $5,370,776 into common shares.
The ability of the Company to continue as a going concern, and to realize its assets and discharge its liabilities when due, is dependent upon its ability to achieve and maintain profitable operations in the future and to secure sufficient financing to fund ongoing investments in its operations.
The Company continues to generate revenues from a combination of engineering services and new product sales. Growth in future revenues is dependent on developing and commercializing additional products, further development of on-going collaborations, strategic partnerships or other transactions with third parties, and merger and acquisition opportunities. Management estimates that the Company’s working capital is sufficient to fund its operations into the 2nd quarter of 2022. There is no certainty that the Company will ultimately achieve profitable operations, become cash flow positive, or raise additional debt and/or equity capital.
These unaudited interim condensed consolidated financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. If the going concern basis was not appropriate for these unaudited interim condensed consolidated financial statements, then adjustments would be necessary to the carrying value of assets and liabilities, the reported revenues and expenses, and the statement of financial position classifications used. These adjustments could be material.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
3. Adoption of accounting standards and interpretations
New accounting standards and interpretations not yet adopted
The IASB issued the following standards that have not been applied in preparing these unaudited interim condensed consolidated financial statements as their effective dates fall within annual periods beginning subsequent to the current reporting period.
Classification of Liabilities as Current or Non-current (Amendments to IAS 1)
On January 23, 2020, the IASB issued amendments to IAS 1 Presentation of Financial Statements, to clarify the classification of liabilities as current or non-current. On July 15, 2020 the IASB issued an amendment to defer the effective date by one year. The amendments removed the requirement for a right to defer settlement or roll over of a liability for at least twelve months to be unconditional. Instead such a right must have substance and exist at the end of the reporting period. The amendments are effective for annual periods beginning on or after January 1, 2023. Early adoption is permitted.
The application of this amendment is not expected to have a material impact to the Company.
Property, Plant and Equipment — Proceeds before Intended Use (Amendments to IAS 16)
On May 14, 2020, the IASB issued Property, Plant and Equipment — Proceeds before Intended Use (Amendments to IAS 16). The amendments clarify that proceeds from selling items before the related item of Property, Plant and Equipment is available for use should be recognised in profit or loss, together with the cost of producing those items. The amendments are effective for annual periods beginning on or after January 1, 2022. Early adoption is permitted.
The application of this amendment is not expected to have a material impact to the Company.
Onerous Contracts – Cost of Fulfilling a Contract (Amendments to IAS 37)
On May 14, 2020, the IASB issued Onerous Contracts – Cost of Fulfilling a Contract (Amendments to IAS 37). This amendment clarifies which costs are included as a cost of fulfilling a contract when determining whether a contract is onerous. The amendments are effective for annual periods beginning on or after January 1, 2022 and apply to contracts existing at the date when the amendments are first applied. Early adoption is permitted.
The application of this amendment is not expected to have a material impact to the Company.
There are no other standards, interpretations or amendments to existing standards that are not yet effective that are expected to have a material impact on the unaudited interim condensed consolidated financial statements of the Company.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
4. Related party transactions
During the period, the Company entered into several related party transactions in the normal course of business. These transactions have been recorded at the agreed upon amounts between the parties.
Amount due from (to) related party is as follows:
| | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
Due from (to) Lamda Guard Technologies Ltd (“LGTL”) – a shareholder, net [1] | | | 61,199 | | | | (312,528 | ) |
Transactions with related parties were as follows:
| | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
Technology license fees [2] | | | 525 | | | | 9,868 | |
Consulting fees [3] | | | 30,000 | | | | 71,840 | |
Rent and utility reimbursement from LGTL [4] | | | (11,776 | ) | | | (11,740 | ) |
| | | 18,749 | | | | 69,968 | |
| [1] | On March 16, 2021, the Company converted an amount of $367,944 owing to its creditor Lamda Guard Technologies Ltd. (“LGTL”) into 81,584 shares of the common shares of the Company for a price per share of $4.51. The purchase price of $4.51 per share represents a 10% premium to the $4.10 closing price of META shares on the CSE at the close on March 12, 2021. The Company has recognized the common shares issued in the consolidated statements of changes in shareholders’ equity at fair value at time of conversion to be $281,465 and recorded the difference of $86,479 between the fair value of the common shares and the carrying value of the liability as loss on debt settlement in the consolidated statements of loss and comprehensive loss. |
| [2] | The Company entered into a Technology Agreement with LGTL on March 28, 2013 which was amended on April 3, 2020. The Technology Agreement will continue until the Company delivers notice of termination to LGTL. Under the agreement, the Company pays a monthly technology license fee. |
| [3] | The Company incurred consulting fees to directors of the Company and to Versa Tech Consulting Ltd., which is owned by a director of the Company. |
| [4] | LGTL uses a portion of the UK premises of Medical Wireless Sensing Limited (“MediWise”), a subsidiary, and reimburses MediWise for the rent and utilities for that space. |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
5. Property and equipment
Property and equipment consist of the following:
Cost | | 2021 | |
| | As at | | | | | | Foreign | | | | |
| | December 31, | | | | | | exchange | | | As at March | |
| | 2020 | | | Additions | | | differences | | | 31, 2021 | |
| | $ | | | $ | | | $ | | | $ | |
Computer equipment | | | 208,620 | | | | — | | | | (614 | ) | | | 208,006 | |
Computer software | | | 326,643 | | | | — | | | | — | | | | 326,643 | |
Manufacturing equipment | | | 8,461,668 | | | | 1,154,241 | | | | (40,064 | ) | | | 9,575,845 | |
Office furniture | | | 126,346 | | | | — | | | | (186 | ) | | | 126,160 | |
Enterprise Resource Planning | | | 267,694 | | | | — | | | | — | | | | 267,694 | |
Assets under Construction | | | 540,338 | | | | 768,005 | | | | (2,865 | ) | | | 1,305,478 | |
| | | 9,931,309 | | | | 1,922,246 | | | | (43,729 | ) | | | 11,809,826 | |
| | | | | | | | | | | | | | | | |
Accumulated depreciation | | 2021 | |
| | As at | | | | | | Foreign | | | | |
| | December 31, | | | | | | exchange | | | As at March | |
| | 2020 | | | Depreciation | | | differences | | | 31, 2021 | |
| | $ | | | $ | | | $ | | | $ | |
Computer equipment | | | 161,664 | | | | 6,087 | | | | (246 | ) | | | 167,505 | |
Computer software | | | 326,644 | | | | — | | | | — | | | | 326,644 | |
Manufacturing equipment | | | 5,715,510 | | | | 436,683 | | | | (19,118 | ) | | | 6,133,075 | |
Office furniture | | | 106,544 | | | | 2,587 | | | | (126 | ) | | | 109,005 | |
Enterprise Resource Planning | | | 105,424 | | | | 13,385 | | | | — | | | | 118,809 | |
| | | 6,415,786 | | | | 458,742 | | | | (19,490 | ) | | | 6,855,038 | |
Net book value | | | 3,515,523 | | | | | | | | | | | | 4,954,788 | |
| | | | | | | | | | | | | | | | |
Cost | | 2020 | |
| | As at | | | | | | Foreign | | | As at | |
| | December 31, | | | | | | exchange | | | December 31, | |
| | 2019 | | | Additions | | | differences | | | 2020 | |
| | $ | | | $ | | | $ | | | $ | |
Computer equipment | | | 173,840 | | | | 36,769 | | | | (1,989 | ) | | | 208,620 | |
Computer software | | | 326,643 | | | | — | | | | — | | | | 326,643 | |
Manufacturing equipment | | | 7,027,756 | | | | 1,509,788 | | | | (75,876 | ) | | | 8,461,669 | |
Office furniture | | | 126,649 | | | | — | | | | (303 | ) | | | 126,346 | |
Enterprise Resource Planning | | | 267,694 | | | | — | | | | — | | | | 267,694 | |
Assets under Construction | | | — | | | | 559,403 | | | | (19,065 | ) | | | 540,338 | |
| | | 7,922,582 | | | | 2,105,960 | | | | (97,233 | ) | | | 9,931,309 | |
| | | | | | | | | | | | | | | | |
Accumulated depreciation | | 2020 | |
| | As at | | | | | | Foreign | | | As at | |
| | December 31, | | | | | | exchange | | | December 31, | |
| | 2019 | | | Depreciation | | | differences | | | 2020 | |
| | $ | | | $ | | | $ | | | $ | |
Computer equipment | | | 136,702 | | | | 25,506 | | | | (544 | ) | | | 161,664 | |
Computer software | | | 162,403 | | | | 164,241 | | | | — | | | | 326,644 | |
Manufacturing equipment | | | 3,923,789 | | | | 1,831,027 | | | | (39,306 | ) | | | 5,715,510 | |
Office furniture | | | 89,128 | | | | 17,685 | | | | (269 | ) | | | 106,544 | |
Enterprise Resource Planning | | | 51,885 | | | | 53,539 | | | | — | | | | 105,424 | |
| | | 4,363,907 | | | | 2,091,998 | | | | (40,119 | ) | | | 6,415,786 | |
Net book value | | | 3,558,675 | | | | | | | | | | | | 3,515,523 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
For the three months ended March 31, 2021, the Company has excluded non-cash investing activities in the consolidated statements of cash flows of $120,629 (three months ended March 31, 2020 - $Nil) which represents amounts not paid as at period-end.
Property and equipment is pledged as security under a General Security Agreement (a “GSA”) signed in favor of the Royal Bank of Canada (“RBC”) on July 14, 2014, which is related to the Company’s corporate bank account and credit card and includes all property and equipment and intangible assets.
6. Unsecured convertible promissory notes
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
| | Bridge loan | | | Torchlight | | | | | | Bridge loan | | | Torchlight | | | | |
| | (a) | | | (b) | | | Total | | | (a) | | | (b) | | | Total | |
Beginning balance | | | 685,007 | | | | 846,952 | | | | 1,531,959 | | | | — | | | | — | | | | — | |
Issued | | | 5,000,000 | | | | 12,704,800 | | | | 17,704,800 | | | | 500,000 | | | | 1,304,570 | | | | 1,804,570 | |
Interest accrued | | | 22,575 | | | | 139,396 | | | | 161,971 | | | | 3,507 | | | | 16,541 | | | | 20,048 | |
Unrealized foreign currency exchange gain | | | — | | | | (132,726 | ) | | | (132,726 | ) | | | — | | | | (31,005 | ) | | | (31,005 | ) |
Unrealized fair value loss (gain) | | | — | | | | (250,456 | ) | | | (250,456 | ) | | | 181,500 | | | | (443,153 | ) | | | (261,653 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
Realized fair value loss | | | 24,298,152 | | | | — | | | | 24,298,152 | | | | — | | | | — | | | | — | |
Conversion to common shares | | | (30,005,734 | ) | | | — | | | | (30,005,734 | ) | | | — | | | | — | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Ending balance | | | — | | | | 13,307,966 | | | | 13,307,966 | | | | 685,007 | | | | 846,953 | | | | 1,531,960 | |
| a) | On November 2020, the Company entered into a commitment letter (the “Commitment Letter”) with a shareholder of the Company, pursuant to which the shareholder will provide up to $5,500,000 in debt financing (the “Bridge Loan”) to fund META’s continued operations while the Company works toward completion of the Proposed Transaction with Torchlight. Pursuant to the Commitment Letter, the Company will be able to draw up to $500,000 monthly beginning in November 2020. The Bridge Loan bears interest at the rate of 8% per annum, payable monthly in arrears. The principal amount and any accrued but unpaid interest will be due and payable on the 10th business day after the closing of the Proposed Transaction, or on November 29, 2022 if the Transaction does not close before that date. |
At the option of the holder, the Bridge Loan, or any portion of the Bridge Loan and accrued but unpaid interest is convertible into META Common Shares at a conversion price of $0.50 per share, subject to customary adjustments. The Company may repay the Bridge Loan in whole or in part, without penalty, at any time on or after March 28, 2021.
The conversion option is an embedded derivative that is subsequently measured at fair value through profit or loss. The Company has chosen to record the promissory note at fair value through profit or loss rather than to account for the debt instrument and the derivative liability separately.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
On February 16, 2021, the total ‘Bridge Loan’ of $5,526,082 of principal and accrued interest was converted at $0.50 per share into 11,052,164 shares of the Company, in accordance with the terms of the bridge financing. The Company has remeasured the liability as of the conversion date and recognized a non-cash realized fair value loss of $24,298,152. The Company has subsequently reclassified the remeasured liability into common shares in the consolidated statements of changes in shareholders’ equity.
| b) | On September 15, 2020, the Company entered into a non-binding Letter of Intent (the “LOI”) with Torchlight Energy Resources Inc. (“Torchlight”) pursuant to which, Torchlight loaned the Company three unsecured convertible promissory notes of total value US$11,000,000. These Unsecured Convertible Promissory Note bears interest at 8% annually, with principal and interest due and payable on the maturity date. If the Company and Torchlight do not enter into a Definitive Agreement, or the Definitive Agreement is terminated, then the Unsecured Convertible Promissory Notes and all accrued and unpaid interest are convertible at the option of the holder into common shares of the Company at the conversion prices set out below. The Company may repay all or part of the Unsecured Convertible Promissory Notes, plus any accrued and unpaid interest, without penalty on or after 120 days from the note issuance date. |
| | Tranche 1 | | Tranche 2 | | Tranche 3 |
Face value of notes issued | | US$500,000 | | US$500,000 | | US$10,000,000 |
Issuance date | | September 20, 2020 | | December 16, 2020 | | February 18, 2021 |
Maturity date | | September 20, 2022 | | December 16, 2022 | | February 18, 2022 |
Interest rate | | 8% | | 8% | | 8% |
Conversion price | | CA$0.35 | | CA$0.62 | | CA$2.80 |
The conversion option is a foreign currency embedded derivative as the note is denominated in USD and the conversion price is in Canadian dollars. The Company has chosen to record the promissory notes at fair value through profit or loss rather than to separately account for the debt instrument and the derivative liability separately. The Company has remeasured the liability at March 31, 2021 and recognized an unrealized fair value gain of $250,456 on liability in the consolidated statements of loss and comprehensive loss.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
7. Secured convertible debentures
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
| | | | | | | | |
Beginning balance | | | 7,060,493 | | | | — | |
Issued | | | — | | | | 5,000,000 | |
Interest accrued | | | 154,512 | | | | 678,355 | |
Interest paid | | | (81,818 | ) | | | (380,273 | ) |
Unrealized fair value loss | | | — | | | | 1,762,411 | |
Realized fair value loss | | | 20,805,046 | | | | — | |
Conversion to common shares | | | (27,938,233 | ) | | | — | |
Ending balance | | | — | | | | 7,060,493 | |
On April 3, 2020, the Company issued $5,000,000 in Secured Debentures to BDC Capital Inc.(“BDC”), a wholly-owned subsidiary of the Business Development Bank of Canada. The Secured Debentures mature on October 31, 2024, and bear interest at a rate of 10.0% per annum, payable monthly in cash. In addition to the cash interest, the Secured Debentures also accrue a non-compounding payment in kind (“PIK”) of 8% per annum. The PIK may get reduced by up to 3% (reduced to as low as 5% per annum) upon meeting certain conditions. BDC may elect to have the PIK paid in cash.
The Secured Debentures and the PIK are convertible in full or in part, at BDC’s option, into META common shares at any time prior to their maturity at a conversion price of $0.70 (the “Conversion Price”) or META may force the conversion of Secured Debentures if META’s common shares are trading on the CSE on a volume-weighted average price greater than 100% of the Conversion Price (i.e. greater than $1.40) for any 20 consecutive trading days with a minimum daily volume of at least 100,000 Common Shares.
The conversion option is an embedded derivative that is subsequently measured at fair value through profit or loss. The Company has chosen to record the Secured Debentures at fair value through profit or loss rather than to separately account for the debt instrument and the derivative liability separately.
The secured debentures are subject to a covenant clause, whereby the Company is required to maintain a working capital ratio of no less than 3:1. Working capital ratio excludes deferred revenue and deferred government assistance from current liabilities. The Company did not fulfil the ratio as required in the contract and consequently, the secured debentures were reclassified as a current liability as at December 31, 2020.
On March 3, 2021, the Company forced the conversion of the Secured Debentures pursuant to the terms of the agreement with BDC. The total debentures balance of $5,370,776 was converted at $0.70 per share into 7,672,537 common shares. The Company has remeasured the liability as of the conversion date and recognized a non-cash realized fair value loss of $20,805,046. The Company has subsequently reclassified the remeasured liability into common shares in the consolidated statements of changes in shareholders’ equity. All security interests held by BDC on assets of the Company were immediately discharged.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
8. Unsecured convertible debentures
Unsecured convertible debentures [the “Unsecured Debentures”] consist of the following:
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
| | | | | | | | |
Beginning balance | | | 2,324,086 | | | | 760,145 | |
Issued | | | — | | | | 950,000 | |
Interest accrued | | | 30,000 | | | | 196,838 | |
Unrealized fair value loss | | | — | | | | 417,102 | |
Realized fair value loss | | | 4,963,915 | | | | — | |
Conversion to common shares | | | (7,318,001 | ) | | | — | |
Ending balance | | | — | | | | 2,324,085 | |
On December 10, 2019, an agreement was signed to convert an existing $250,000 short-term loan into an Unsecured Debenture, and also during December 2019, the Company issued an additional $500,000 in Unsecured Debentures to the same investor, under the same terms.
During the year ended December 31, 2020, the Company issued an additional $950,000 in Unsecured Debentures to individuals and companies under the same terms as previous issues.
The Unsecured Debentures bear interest at a fixed rate of 1% per month, compounding monthly and have a maturity date of April 30, 2025. Each Unsecured Debenture is convertible at the option of the holder into common shares of META at a price of $0.70 per share. Following completion of the RTO, META may elect to repay the outstanding amounts owing under the Unsecured Debentures in cash or in shares at conversion price of $0.70 of the Resulting Issuer upon meeting certain conditions or the holder can convert the Unsecured Debentures at $0.70 or the Unsecured Debentures can be converted at maturity at the greater of 80% of 10 day volume-weighted average price of the Resulting Issuer’s common shares or the closing price on the preceding trading day less the maximum permitted discount by the exchange.
The conversion option is an embedded derivative that is subsequently measured at fair value through profit or loss. The Company has chosen to record the Unsecured Debentures at fair value through profit or loss rather than to account for the debt instrument and the derivative liability separately.
On February 16, 2021, the Company converted $1,936,984 of principal and accrued interest of Unsecured Debentures at $0.70 per share into 2,767,120 common shares of the Company in accordance with the terms of their debt instruments. The Company has remeasured the liability as of the conversion date and recognized a non-cash realized fair value loss of $4,963,915. The Company has subsequently reclassified the remeasured liability into common shares in the consolidated statements of changes in shareholders’ equity.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
9. Long-term debt
| | March 31, | | | December 31, | |
| | 2021 | | | 2020 | |
| | $ | | | $ | |
ACOA Business Development Program (“BDP”) 2012 interest-free loan1 with a maximum contribution of $500,000, repayable in monthly repayments commencing October 1, 2015 of $5,952 until June 1, 2023. Loan repayments were temporarily paused effective April 1, 2020 until January 1, 2021 as a result of the COVID-19 outbreak. As at March 31, 2021, the amount drawn down on the loan, net of repayments, is $160,715 (2020 - $178,571). | | | 149,391 | | | | 164,732 | |
ACOA Atlantic Innovation Fund (“AIF”) 2015 interest-free loan1,2 with a maximum contribution of $3,000,000. Annual repayments, commencing June 1, 2021, are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than $1,000,000, 5% when gross revenues are less than $10,000,000 and greater than $1,000,000, and $500,000 plus 1% of gross revenues when gross revenues are greater than $10,000,000. As at March 31, 2021, the amount drawn down on the loan is $3,000,000 (2020 - $3,000,000). | | | 1,936,665 | | | | 1,857,540 | |
ACOA BDP 2018 interest-free loan1,3 with a maximum contribution of $3,000,000, repayable in monthly repayments commencing June 1, 2021 of $31,250 until May 1, 2029. As at March 31, 2021, the amount drawn down on the loan, net of repayments, is $3,000,000 (2020 - $3,000,000). | | | 1,698,590 | | | | 1,636,453 | |
ACOA BDP 2019 interest-free loan1 with a maximum contribution of $100,000, repayable in monthly repayments commencing June 1, 2021 of $1,400 until May 1, 2027. As at March 31, 2021, the amount drawn down on the loan is $62,165 (2020 - $62,165). | | | 39,831 | | | | 38,372 | |
ACOA Regional Relief and Recovery Fund (“RRRF”) 2020 interest-free loan with a maximum contribution of $390,000, repayable on monthly repayments commencing April 1, 2023 of $11,000 until April 1, 2026. As at March 31, 2021, the amount drawn down on the loan is $390,000 (2020 - $Nil). | | | 117,141 | | | | — | |
Shareholder loan bearing no interest. The loan proceeds are provided as collateral to a letter of credit and are recorded as restricted cash. The loan is repayable upon any reduction of the letter of credit. In the event that the bank draws on the collateral or the collateral has not been returned in full by December 31, 2021, then the outstanding balance of collateral will be considered a demand promissory note with 1% interest charge per month compounded monthly beginning January 1, 2022. | | | 1,000,000 | | | | — | |
CAIXA Capital loan bearing interest at 6-month EURIBOR rate plus 4% interest spread. The loan principal and interest are fully repayable on January 15, 2025. On March 12, 2021, the principal loan balance with outstanding interest totaling EUR 171,080 (CAD $261,735) was converted into common shares of the Company at $3.87 per share4. Pursuant to the conversion, CAIXA Capital was issued 67,597 common shares of the Company. | | | — | | | | 165,853 | |
| | | 4,941,618 | | | | 3,862,950 | |
Less: current portion | | | 1,185,756 | | | | 369,921 | |
| | | 3,755,862 | | | | 3,493,029 | |
| 1 | The Company was required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for June 30, 2019 and for each period thereafter until the loan is fully repaid. |
| 2 | The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, based on a number of assumptions, discounted at the original effective interest rate. |
| 3 | A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment, accordingly $548,055 was recorded in the consolidated statements of financial position as deferred government assistance, which is being amortized over the useful life of the associated equipment. The Company recorded the amortization expense for the period ended March 31, 2021 of $45,671 (period ended March 31, 2020 - $45,671) as government assistance in the consolidated statements of loss and comprehensive loss. |
| 4 | The Company has recognized the common shares issued in the consolidated statements of changes in shareholders’ equity at fair value at time of conversion to be $277,148 and recorded the difference of $110,891 between the fair value of the common shares and the carrying value of the long-term debt as loss on debt settlement in the consolidated statements of loss and comprehensive loss. |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
10. Capital stock
Common shares
Authorized: Unlimited number of common shares, no par value
The following table summarizes the change in issued common shares of the Company:
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | Number of | | | | | | Number of | | | | |
| | shares | | | Amount | | | shares | | | Amount | |
| | # | | | $ | | | # | | | $ | |
| | | | | | | | | | | | |
Balance, beginning of period | | | 83,557,679 | | | | 34,248,734 | | | | 10,504,573 | | | | 7,598,670 | |
Issued, net | | | — | | | | — | | | | 515,067 | | | | 588,254 | |
Conversion of preferred shares | | | — | | | | — | | | | 9,398,984 | | | | 12,748,100 | |
Conversion of secured promissory notes | | | — | | | | — | | | | 3,498,825 | | | | 5,948,003 | |
Conversion of deferred shared units | | | — | | | | — | | | | 103,000 | | | | 55,100 | |
Share-based compensation | | | — | | | | — | | | | 58,823 | | | | 76,696 | |
| | | 83,557,679 | | | | 34,248,734 | | | | 24,079,272 | | | | 27,014,823 | |
Conversion of unsecured promissory notes [note 6] | | | 11,052,164 | | | | 30,005,734 | | | | — | | | | — | |
Conversion of secured debentures [note 7] | | | 7,672,537 | | | | 27,938,233 | | | | — | | | | — | |
Conversion of unsecured debentures [note 8] | | | 2,767,121 | | | | 7,318,001 | | | | — | | | | — | |
Conversion of long-term debt [note 9] | | | 67,597 | | | | 277,148 | | | | — | | | | — | |
Conversion of due to related party [note 4] | | | 81,584 | | | | 281,465 | | | | — | | | | — | |
Options exercises | | | 96,867 | | | | 101,920 | | | | — | | | | — | |
Warrants exercises | | | 44,497 | | | | 56,240 | | | | — | | | | — | |
Broker Warrants exercises | | | 33,242 | | | | 34,421 | | | | — | | | | — | |
Share-based compensation | | | 155,172 | | | | 90,000 | | | | — | | | | — | |
Resultant Issuer common shares issued to MTI shareholders [1] | | | — | | | | — | | | | 47,810,924 | | | | | |
Fair value of deemed issuance to CPM | | | — | | | | — | | | | 11,706,896 | | | | 7,258,276 | |
Tax withheld on deferred shared units | | | — | | | | — | | | | (39,413 | ) | | | (24,365 | ) |
Balance, end of period | | | 105,528,460 | | | | 100,351,896 | | | | 83,557,679 | | | | 34,248,734 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
[1] Resultant Issuer common shares issued to MTI shareholders were calculated as follow:
| | Beginning | | | Issued, | | | Pre | | | | | | Post | | | | |
| | balance | | | net | | | RTO | | | Conversion | | | RTO | | | Change | |
| | # | | | # | | | # | | | Ratio | | | # | | | # | |
| | | | | | | | | | | | | | | | | | |
Common shares | | | 10,504,573 | | | | 515,067 | | | | 11,019,640 | | | | 2.750 | | | | 30,303,992 | | | | 19,284,352 | |
Preferred shares - class A1 | | | 5,273,720 | | | | — | | | | 5,273,720 | | | | 2.750 | | | | 14,502,722 | | | | 9,229,002 | |
Preferred shares - class A2 | | | 4,125,264 | | | | — | | | | 4,125,264 | | | | 4.125 | | | | 17,016,705 | | | | 12,891,441 | |
Promissory notes | | | — | | | | 3,498,825 | | | | 3,498,825 | | | | 2.750 | | | | 9,621,764 | | | | 6,122,939 | |
Deferred shared units (“DSUs”) | | | — | | | | 103,000 | | | | 103,000 | | | | 2.750 | | | | 283,250 | | | | 180,250 | |
Share-based compensation | | | — | | | | 58,823 | | | | 58,823 | | | | 2.750 | | | | 161,763 | | | | 102,940 | |
| | | 19,903,557 | | | | 4,175,715 | | | | 24,079,272 | | | | | | | | 71,890,196 | | | | 47,810,924 | |
During the three months ended March 31, 2021, the Company converted unsecured convertible promissory notes of 30,005,734, secured convertible debentures of $27,938,233, unsecured convertible debentures of $7,318,001 into common shares. The Company remeasured the financial liabilities at fair value as of respective conversion dates and recognized a non-cash realized loss of $50,067,114. The Company subsequently reclassified the remeasured liability into common shares. The number of shares issued were calculated as the total outstanding principal and interest of each liability multiplied by the conversion price stated in the agreement.
During the three months ended March 31, 2021, the Company converted long-term debt of $166,256 and due to related party of $367,944 into common shares. The Company recorded the common shares issued at fair value using the Company’s share price at the time of conversion. The difference between the fair value of common shares and the carrying value of the liabilities of $24,412 was recorded in finance cost in the consolidated statements of loss and comprehensive losses. The number of shares issued were calculated as the total outstanding principal and interest of each liability multiplied by the agreed upon conversion price.
During the three months ended March 31, 2021, an employee and a consultant exercised 96,867 options with a weighted average exercise price of $0.64 per share for proceeds of $61,658.
During the three months ended March 31, 2021, a shareholder exercised 44,497 warrants with an exercise price of $0.64 per share for proceeds of $40,047. In addition, 33,242 broker warrants were exercised with an exercise price of $0.62 per share for proceeds of $20,610.
During the three months ended March 31, 2021, the Company issued 155,172 shares at $0.58 per share as share-based compensation in exchange for fairness opinion with respect to the Torchlight RTO. The Company paid $90,000 in cash in 2020 and agreed to settle the remaining $90,000 in common shares. The Company has recognized the share-based payment in trade and other payables in 2020 until the shares were issued in 2021.
During the three months ended March 31, 2020, the Company received gross proceeds of $875,612 for subscriptions of 515,067 units, comprised of 515,067 common shares and 515,067 of the Company’s warrants as part of a private placement, expiring on the second anniversary of the RTO as per the extended expiry approved by the board on February 28, 2020, which were ascribed a value of $204,054. Additionally, in relation to the private placement, the Company incurred share issuance costs of $61,342, and issued 19,225 broker warrants as finder’s fees, which were ascribed a value of $21,962. The broker warrants expire on the second anniversary of the RTO as per the extended expiry approved by the board on February 28, 2020. For every broker warrant, warrant holders shall have the right to purchase one common share at a post RTO exercise price of $0.62.
In January 2020, the Company settled 103,000 DSU’s through the issuance of common shares of MTI for a total value of $55,100.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
In March 2020 and pursuant to the RTO, all preferred shares were converted into 9,398,984 common shares of MTI. See preferred share section below for additional details.
In March 2020 and pursuant to the RTO, the aggregate principal of the Promissory Notes and all interest accrued up until January 28, 2020 were converted into 3,498,825 common shares of MTI.
In December 2020, the Company has withheld 39,413 common shares equivalent to $24,365 from the 2019 DSU’s settlement representing tax withheld and remitted to CRA on behalf of 2 former directors.
During the year ended December 31, 2019, the Company has approved advisory fees for a director and a former director of $100,000, net of taxes, to be paid in units, consisting of a share and a warrant, from treasury, upon closing of the RTO. The Company has recognized $70,000 as consulting fees, based on expected probability of 70% for the completion of the RTO at December 31, 2019 with the amount recorded in contributed surplus. During the year ended December 31, 2020, the remaining $30,000 was recognized as consulting fees and the balance of $100,000 recorded in contributed surplus was converted into warrants and common shares upon completion of the RTO. In addition, during the year ended December 31, 2020, the company recognized related taxes of $46,168 (2019 - $57,582) as consulting fees.
The Company has allocated the consideration of $100,000 to warrants and common shares based on the relative fair value of the warrant and the shares. Accordingly, $76,696 has been allocated to common shares and $23,304 has been allocated to warrants.
Warrants
Prior to completion of the RTO on March 5, 2020, every two warrants had the right to purchase one MTI common share for $2.475 per share.
Pursuant to the completion on the RTO on March 5, 2020, the warrants were adjusted such that one warrant has the right to purchase one Resultant Issuer Common Share for $0.90 per share.
The following table summarizes the changes in warrants of the Company:
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | Number of | | | | | | Number of | | | | |
| | warrants | | | Amount | | | warrants | | | Amount | |
| | # | | | $ | | | # | | | $ | |
| | | | | | | | | | | | |
Balance, beginning of period | | | 1,651,352 | | | | 543,484 | | | | 627,097 | | | | 175,095 | |
Issued | | | — | | | | — | | | | 573,890 | | | | 227,358 | |
Adjustment to 2019 warrants | | | — | | | | — | | | | — | | | | 141,031 | |
| | | 1,651,352 | | | | 543,484 | | | | 1,200,987 | | | | 543,484 | |
Conversion of MTI warrants into META warrants pursuant to the RTO | | | — | | | | — | | | | 450,365 | | | | — | |
Exercised | | | (44,497 | ) | | | (16,193 | ) | | | — | | | | — | |
Balance, end of period | | | 1,606,855 | | | | 527,291 | | | | 1,651,352 | | | | 543,484 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
The following table summarizes the changes in broker warrants of the Company:
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | Number of | | | | | | Number of | | | | |
| | warrants | | | Amount | | | warrants | | | Amount | |
| | # | | | $ | | | # | | | $ | |
| | | | | | | | | | | | |
Balance, beginning of period | | | 52,861 | | | | 21,962 | | | | — | | | | — | |
Issued | | | — | | | | — | | | | 19,225 | | | | 21,962 | |
| | | 52,861 | | | | 21,962 | | | | 19,225 | | | | 21,962 | |
Conversion of MTI broker warrants into META broker warrants pursuant to the RTO | | | — | | | | — | | | | 33,636 | | | | — | |
Exercised | | | (33,242 | ) | | | (13,811 | ) | | | — | | | | — | |
Balance, end of period | | | 19,619 | | | | 8,151 | | | | 52,861 | | | | 21,962 | |
Prior to the completion of the RTO on March 5, 2020, each broker warrant had the right to purchase one MTI common share for $1.70 per share and pursuant to the completion of the RTO the broker warrants were adjusted such that each broker warrant has the right to purchase one Resultant Issuer Common Share for $0.62 per share.
During the year ended December 31, 2020, the Company issued 58,823 warrants to two directors related to advisory services as well as 515,067 warrants to investors and 19,225 broker warrants as a finders fee pursuant to its private placement of shares.
There were no warrants granted during the three months ended March 31, 2021. The fair value of warrants and broker warrants issued during 2020 were estimated using the Black-Scholes option pricing model with the following inputs and assumptions:
| | Year ended | |
| | December 31, 2020 | |
Risk free interest rate | | 0.80% - 1.43% | |
Expected volatility | | 134% | |
Expected dividend yield | | 0% | |
Expected forfeiture rate | | 0% | |
MTI common share price | | 1.70 | |
Exercise price per MTI common share | | $1.70 - $2.475 | |
Expected term of warrants | | 24 Months post RTO | |
11. Share-based payments
DSU Plan
On March 28, 2013, the Company implemented a DSU Plan for its directors, employees and officers. Directors, employees and officers are granted DSUs of the Company as a form of compensation. Each unit is convertible at the option of the holder into one common share of the Company. Eligible individuals are entitled to receive all DSUs [including dividends and other adjustments] no later than December 1 of the first calendar year commencing after the time of termination of their services. The value to be received is the market value of the common shares issued in equity. The value of the DSUs is included in equity.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
The following table summarizes the change in outstanding share DSUs of the Company:
| | Three months ended | | | Year ended | |
| | March 31, 2021 | | | December 31, 2020 | |
| | # | | | # | |
| | | | | | |
Outstanding, beginning of period | | | 1,872,750 | | | | 784,000 | |
Converted into MTI Common Shares | | | — | | | | (103,000 | ) |
Conversion of MTI DSUs into META DSUs pursuant to the RTO | | | — | | | | 1,191,750 | |
Outstanding, end of period | | | 1,872,750 | | | | 1,872,750 | |
Information concerning units outstanding is as follows: |
| | | | | | | | |
| | | March 31, 2021 | | | | December 31, 2020 | |
Issue price | | | Number of units | | | | Number of units | |
$ | | | # | | | | # | |
| | | | | | | | |
0.50 | | | 1,815,000 | | | | 1,815,000 | |
0.95 | | | 57,750 | | | | 57,750 | |
| | | 1,872,750 | | | | 1,872,750 | |
No DSUs were issued during the three months ended March 31, 2021 and the year ended December 31, 2020.
During the year ended December 31, 2020 and prior to the RTO, 103,000 (2019 - 153,000) MTI DSUs were converted into 103,000 (2019 - 153,000) MTI common shares.
On March 5, 2020 and pursuant to the RTO all MTI DSUs were converted into META DSUs at a ratio of 2.75 META DSUs for each MTI DSU.
Employee Stock Option Plan
Each share option is convertible at the option of the holder into one common share of the Company.
The Company has an Employee Stock Option Plan [the “Plan”] for directors, officers, and employees. Unless otherwise determined by the Board of Directors, 25% of the options shall vest and become exercisable on the first anniversary of the grant date and 75% of the shares issuable under the Plan shall vest and become exercisable in equal monthly installments over the three-year period commencing immediately after the first anniversary of the grant date. The option exercise price will not be less than the fair market value of a share on the grant date, as determined by the Board of Directors, taking into account any considerations which it determines to be appropriate at the relevant time.
The exercise price of the share options is equal to the market price of the underlying shares on the date of the grant. The contractual term of the share options is 10 years and there are no cash settlement alternatives for the employees.
During the three months ended March 31, 2021, 96,867 options were exercised by employees. In addition, 18,333 options expired unexercised.
During the year ended December 31, 2020, the Company’s existing MTI options were converted at a ratio of 2.75 META options for each MTI option pursuant to the RTO. Also as part of the RTO, 700,000 META options were issued to executives and directors of CPM. Additionally and subsequent to the completion of the RTO, the Company granted 7,264,000 META options to employees and directors, 487,000 of which vested upon grant and 6,777,000 of which vest over 1-4 years. Prior to the completion of the RTO, 7,500 MTI options were forfeited as a result of employee departures. Subsequent to the completion of the RTO, 1,403,500 META options were forfeited as a result of employee departures and 1,133,261 options expired unexercised.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
During the three months ended March 31, 2021, the Company has recognized employee stock-based compensation of $541,151 (three months ended March 31, 2020 - $450,028) net of forfeitures. Previously recognized expense attributable to unvested options of terminated employees was recognized as a recovery within stock compensation expense in the amount $4,932 (three months ended March 31, 2020 - $567).
The following table summarizes the change in outstanding share options of the Company:
| | Three months ended March 31, 2021 | | | Year ended December 31, 2020 | |
| | Weighted Average exercise price per share option $ | | | Number of options # | | | Weighted Average exercise price per share option $ | | | Number of options # | |
Outstanding, beginning of period | | 0.61 | | | | 13,266,936 | | | | 1.66 | | | | 2,858,300 | |
Forfeitures of MTI options | | | | | | — | | | | 1.70 | | | | (7,500 | ) |
| | 0.61 | | | | 13,266,936 | | | | 1.66 | | | | 2,850,800 | |
Conversion of MTI options into META options pursuant to the RTO | | | | | | — | | | | | | | | 4,988,897 | |
Issued to CPM executives and directors pursuant to RTO | | | | | | — | | | | 0.35 | | | | 700,000 | |
Granted | | | | | | — | | | | 0.62 | | | | 7,264,000 | |
Forfeitures | | 0.62 | | | | (18,333 | ) | | | 0.62 | | | | (1,403,500 | ) |
Exercised | | 0.64 | | | | (96,867 | ) | | | | | | | — | |
Expired | | | | | | — | | | | 0.50 | | | | (1,133,261 | ) |
Outstanding, end of period | | 0.61 | | | | 13,151,736 | | | | 0.61 | | | | 13,266,936 | |
Below is a summary of the outstanding options as at March 31, 2021:
Exercise price | | Number outstanding | | | Number exercisable | |
$ | | 2021 # | | | 2021 # | |
| | | | | | |
0.27 (0.75 pre-RTO) | | | 302,500 | | | | 302,500 | |
0.35 (issued post RTO) | | | 200,000 | | | | 200,000 | |
0.62 (1.70 pre-RTO) | | | 12,649,236 | | | | 7,345,598 | |
| | | 13,151,736 | | | | 7,848,098 | |
Below is a summary of the outstanding options as at December 31, 2020:
Exercise price | | | Number outstanding | | | | Number exercisable | |
$ | | | 2020 # | | | | 2020 # | |
| | | | | | | | |
0.27 (0.75 pre-RTO) | | | 302,500 | | | | 302,500 | |
0.35 (issued post RTO) | | | 200,000 | | | | 200,000 | |
0.62 (1.70 pre-RTO) | | | 12,764,436 | | | | 3,439,689 | |
| | | 13,266,936 | | | | 3,942,189 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
The weighted average remaining contractual life for the share options outstanding as at March 31, 2021 was 8.09 (December 31, 2020 8.36) years. The weighted average fair value of META options granted during the three months ended March 31, 2021 was $Nil (year ended December 31, 2020 - $0.52).
There were no options granted during the three months ended March 31, 2021. The fair value of options granted during 2020 were estimated on the date of grant using the Black-Scholes option pricing model with the following inputs and assumptions:
| | Employee | |
| | Stock | |
| | Option Plan | |
| | 2020 | |
| | |
Weighted average common share fair value at the measurement date | | $ | 0.52 | |
Exercise price for options Issued to CPM executives and directors | | $ | 0.35 | |
Exercise price for all other options | | $ | 0.62 | |
Dividend yield [%] | | | — | |
Expected volatility for options having 10 years expiry | | | 52%-117% | |
Expected volatility for options having 3 years expiry | | | — | |
Expected volatility for options having 6 month expiry | | | 134% | |
Weighted average risk-free interest rate | | | 0.73% | |
Weighted average expected life of the options | | | 7.48 years | |
The expected life of the options is based on historical data and current expectations and is not necessarily indicative of exercise patterns that may occur. The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.
12. Capital management
The primary objective of the Company’s capital management is to achieve healthy capital ratios to support its business and maximize shareholder value. The Company’s capital structure consists of share capital, warrants, contributed surplus, promissory notes, secured and unsecured debentures, funding obligation and long-term debt, which as at March 31, 2021 was $126,468,790 (December 31, 2020 - $56,387,088). The Company monitors equity on the basis of the carrying amount of equity as presented on the interim condensed consolidated statements of financial position.
No changes were made to the objectives, policies and processes for capital management for the periods ended March 31, 2021 and December 31, 2020.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
13. Additional cash flow information
The net changes in non-cash working capital balances related to operations consist of the following:
| | Three months ended | | | Three months ended | |
| | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Grants receivable | | | 38,619 | | | | 120,647 | |
Inventory | | | 160,951 | | | | (211,627 | ) |
Other receivables | | | (126,001 | ) | | | (302,482 | ) |
Prepaid expenses | | | 39,029 | | | | (76,165 | ) |
HST receivable | | | 25,241 | | | | 171,610 | |
Trade payables | | | (205,062 | ) | | | (1,819,419 | ) |
Due from (to) related party | | | (115,042 | ) | | | 6,445 | |
| | | (182,265 | ) | | | (2,110,991 | ) |
The net changes in liabilities arising from financing activities consist of the following:
| | Three months ended | | | Three months ended | |
| | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Current portion of long-term debt, beginning of period | | | 369,921 | | | | 104,376 | |
Long-term debt, beginning of period | | | 3,493,029 | | | | 3,139,301 | |
Carrying amount, beginning of period | | | 3,862,950 | | | | 3,243,677 | |
Scheduled repayments of long-term debt | | | (17,857 | ) | | | (25,658 | ) |
Net proceeds from loans, net of financing costs | | | 1,390,000 | | | | 35,075 | |
Non-cash changes in long-term debt: | | | | | | | | |
Interest accrued | | | — | | | | 403 | |
Interest accretion | | | 149,781 | | | | 109,954 | |
Interest expense | | | 5,169 | | | | 8,021 | |
Fair market value adjustment | | | (277,403 | ) | | | (16,084 | ) |
Foreign exchange gain on long-term debt | | | (4,765 | ) | | | 6,647 | |
Loss on debt conversion | | | 110,891 | | | | — | |
Conversion to common shares | | | (277,148 | ) | | | — | |
Carrying amount, end of period | | | 4,941,618 | | | | 3,362,035 | |
Less current portion | | | (1,185,756 | ) | | | (107,809 | ) |
| | | 3,755,862 | | | | 3,254,226 | |
14. Financial instruments
The Company’s financial liabilities include trade payables, due from related party, funding obligation, unsecured convertible promissory notes, secured and unsecured convertible debentures and long-term debt. The Company’s financial assets include cash and cash equivalents, restricted cash, grants receivable, other receivables and due from related party. The Company’s financial instruments have been classified as either assets or liabilities at amortized cost, or financial liabilities at fair value through profit and loss.
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
The following table illustrates how the positions in the interim condensed consolidated statements of financial position are classified and measured:
Financial asset/liability | | Classification and measurement |
Cash and cash equivalents | | Amortized cost |
Restricted Cash | | Amortized cost |
Grants receivable | | Amortized cost |
Other receivables | | Amortized cost |
Due from related party | | Amortized cost |
Trade payables | | Other financial liabilities at amortized cost |
Funding obligation | | Amortized cost |
Unsecured convertible promissory notes | | Fair value through profit and loss |
Secured convertible debentures | | Fair value through profit and loss |
Unsecured convertible debentures | | Fair value through profit and loss |
Lease Liabilities | | Amortized cost |
Long-term debt | | Loans and borrowings at amortized cost |
The risks arising from the Company’s financial instruments are interest rate risk, foreign currency risk, and liquidity risk.
Fair value risk
The Company uses a fair value hierarchy, based on the relative objectivity of inputs used to measure fair value, with Level 1 representing inputs with the highest level of objectivity and Level 3 representing the lowest level of objectivity.
The fair values of grants receivable, other receivables, and trade payables approximate their carrying values due to the short-term maturity of these financial instruments. The fair value of due to related parties approximates their carrying value due to the market-based rates.
The fair values of long-term debt, funding obligation and lease liabilities are classified at Level 3 in the fair value hierarchy as it is estimated based on unobservable inputs including discounted cash flows using the market rate, which is subject to similar risks and maturities with comparable financial instruments as at the reporting date.
The Company has chosen to record the unsecured convertible promissory notes as well as secured and unsecured convertible debentures at fair value through profit or loss rather than to account for the debt instrument and the derivative liability separately.
The following table sets out the approximate fair values of financial instruments as at the consolidated statements of financial position date:
| | March 31, 2021 | | | December 31, 2020 | |
| | Carrying value | | | Fair value | | | Carrying value | | | Fair value | |
Financial asset/liability | | $ | | | $ | | | $ | | | $ | |
Cash and cash equivalents | | | 15,187,356 | | | | 15,187,356 | | | | 1,776,983 | | | | 1,776,983 | |
Restricted Cash | | | 1,000,000 | | | | 1,000,000 | | | | — | | | | — | |
Grants receivable | | | 378,058 | | | | 378,058 | | | | 417,442 | | | | 417,442 | |
Other receivables | | | 175,074 | | | | 175,074 | | | | 50,330 | | | | 50,330 | |
Due from related party | | | 61,199 | | | | 61,199 | | | | — | | | | — | |
Trade payables | | | 3,787,844 | | | | 3,787,844 | | | | 3,743,783 | | | | 3,743,783 | |
Due to related party | | | — | | | | — | | | | 312,528 | | | | 312,528 | |
Funding obligation | | | 1,026,686 | | | | 786,457 | | | | 989,128 | | | | 708,737 | |
Unsecured convertible promissory notes | | | 13,307,966 | | | | 13,307,966 | | | | 1,531,960 | | | | 1,531,960 | |
Secured convertible debentures | | | — | | | | — | | | | 7,060,493 | | | | 7,060,493 | |
Unsecured convertible debentures | | | — | | | | — | | | | 2,324,085 | | | | 2,324,085 | |
Lease liabilities | | | 1,660,012 | | | | 1,134,723 | | | | 344,507 | | | | 360,124 | |
Long-term debt | | | 4,941,618 | | | | 3,230,230 | | | | 3,862,950 | | | | 3,402,430 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
Interest rate risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Interest rate risk is minimized through management’s decision to primarily obtain fixed rate or interest free debt. The convertible notes, convertible debentures, funding obligation and long-term debt, except shareholder Loan from Caixa Capital, are at a nil or fixed interest rate and the interest on the cash balances is insignificant. As a result, the Company is not exposed to material cash flow interest rate risk.
Foreign currency risk
Foreign currency risk is the risk to earnings or capital arising from changes in foreign exchange rates. The Company has transactional currency exposures that arise from loans and receivables in currencies other than its functional currency. The Company has transactional currency exposures that arise from purchases in currencies other than their functional currency, including US dollars and Euros. The Company does not enter into derivatives to hedge the exposure.
The impact of foreign currency sensitivity on the Company’s loss before tax is due to the changes in the fair value of monetary assets and liabilities as at the date of financial position. With all other variables held constant the increase or decrease in exchange rates by 5% will result in below mentioned increase or decrease respectively in net loss before tax for the year ended December 31, 2020:
| ● | by $166,858 [December 31, 2020 - $67,285] on account of change in USD exchange rate; |
| ● | by $3,997 [December 31, 2020 - $8,076] on account of change in GBP exchange rate; |
| ● | by $5,508 [December 31, 2020 - $9,633] on account of change in EURO exchange rate. |
Liquidity risk
Liquidity risk represents the risk that the Company will have difficulty meeting obligations of financial liabilities. There can be significant fluctuation in the timing of the Company’s cash receipts due to various external factors. The Company mitigates this risk by regular monitoring of its cash position. Liquidity risk is also related to the possibility of insufficient debt and equity financing available to fund the desired growth of the Company and to refinance the current and long-term debt as they become due. The Company’s financial condition and results of operations could be adversely affected if it were not able to obtain appropriate levels of financing. Contractual maturities of financial liabilities (principal amount):
| | Long- term debt | | | Trade payables | | | Unsecured convertible promissory notes | | | Leases | | | Total | |
| | $ | | | $ | | | $ | | | $ | | | $ | |
| | | | | | | | | | | | | | | |
2021 | | | 353,750 | | | | 3,787,844 | | | | — | | | | 225,499 | | | | 4,367,093 | |
2022 | | | 888,568 | | | | — | | | | 13,832,500 | | | | 355,068 | | | | 15,076,136 | |
2023 | | | 1,314,685 | | | | — | | | | — | | | | 260,000 | | | | 1,574,685 | |
2024 | | | 2,210,088 | | | | — | | | | — | | | | 325,000 | | | | 2,535,088 | |
2025 | | | 517,361 | | | | — | | | | — | | | | 344,500 | | | | 861,861 | |
Thereafter | | | 1,328,428 | | | | — | | | | — | | | | 2,791,333 | | | | 4,119,761 | |
| | | 6,612,880 | | | | 3,787,844 | | | | 13,832,500 | | | | 4,301,400 | | | | 28,534,624 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
15. Deferred revenue
Deferred revenue consists of the following:
| | March 31, 2021 | | December 31, 2020 |
| | $ | | $ |
| | | | |
Covestro - Cooperation Framework | | | 925,126 | | | | — | |
Satair A/S-exclusive rights | | | 1,006,552 | | | | 1,037,990 | |
Satair A/S-advance against PO | | | 622,402 | | | | 622,402 | |
LM Aero-metaSOLAR commercialization | | | 646,374 | | | | 822,658 | |
US Deferred Revenue | | | 94,313 | | | | 95,553 | |
Innovate UK-R&D tax credit | | | 23,848 | | | | 23,908 | |
| | | 3,318,615 | | | | 2,602,511 | |
Less current portion | | | 2,442,747 | | | | 1,578,676 | |
| | | 875,868 | | | | 1,023,835 | |
16. Leases
The carrying amounts in the interim condensed consolidated statements of financial position are as follows:
Right-of-use Assets | | March 31, 2021 | | | December 31, 2020 | |
| | $ | | | $ | |
Opening balance | | | 337,441 | | | | 66,951 | |
Additions | | | 1,300,573 | | | | 411,112 | |
Amortization | | | (80,018 | ) | | | (129,719 | ) |
Unrealized foreign exchange loss | | | (3,001 | ) | | | (10,903 | ) |
Closing balance | | | 1,554,995 | | | | 337,441 | |
| | | | | | | | |
Lease liabilities | | March 31, 2021 | | | December 31, 2020 | |
| | | $ | | | | $ | |
Opening balance | | | 344,507 | | | | 71,947 | |
Additions | | | 1,300,573 | | | | 411,112 | |
Payments | | | (57,620 | ) | | | (149,991 | ) |
Non-cash interest accretion | | | 75,671 | | | | 22,632 | |
Unrealized foreign exchange gain | | | (3,119 | ) | | | (11,193 | ) |
Closing balance | | | 1,660,012 | | | | 344,507 | |
Less: current portion | | | (286,279 | ) | | | (192,001 | ) |
| | | 1,373,733 | | | | 152,506 | |
The amounts recognized in the interim condensed consolidated statements of loss and comprehensive loss are as follows:
| | Three months ended | | | Three months ended | |
| | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Amortization expense of right-to-use assets | | | 80,018 | | | | 20,360 | |
Interest expense on lease liabilities | | | 75,671 | | | | 2,475 | |
| | | 155,689 | | | | 22,835 | |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
17. Finance income and costs
| | Three months ended | | | Three months ended | |
Finance income | | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Fair value gain on interest-free component of long-term debt | | | — | | | | 16,085 | |
Interest income | | | 806 | | | | 265 | |
| | | 806 | | | | 16,350 | |
| | | | | | | | |
| | Three months ended | | | Three months ended | |
Finance costs | | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Interest & Bank charges | | | 385,205 | | | | 120,273 | |
Non-cash interest accretion on long-term debt | | | 149,781 | | | | 109,954 | |
Non-cash interest accretion on funding obligation | | | 37,558 | | | | 30,972 | |
Non-cash interest accretion on lease liabilities | | | 75,671 | | | | 2,475 | |
Loss on liabilities conversion | | | 24,412 | | | | — | |
| | | 672,627 | | | | 263,674 | |
Non-cash finance income and costs for the purposes of the interim condensed consolidated statements of cash flows are as follows:
| | Three months ended | | | Three months ended | |
Non-cash finance income | | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | | | |
Fair value gain on interest-free component | | | — | | | | 16,085 | |
| | | | | | | | |
| | Three months ended | | | Three months ended | |
Non-cash finance costs | | March 31, 2021 | | | March 31, 2020 | |
| | $ | | | $ | |
| | | | | | |
Non-cash interest expense | | | 269,814 | | | | 82,521 | |
Non-cash interest accretion | | | 263,010 | | | | 143,401 | |
Loss on liabilities conversion | | | 24,412 | | | | — | |
| | | 557,236 | | | | 225,922 | |
18. Commitments
| a) | On January 29, 2021, the Company arranged an irrevocable standby letter of credit with Toronto Dominion Bank (“TD”) in favour of Covestro Deutschland AG (“Covestro”) for EUR $600,000 in relation to Cooperation Framework Agreement (“CFA”) (note 15). In the event the Company fails to meet the performance milestones under the CFA, Covestro shall draw from the letter of credit with TD. The letter of credit is secured by restricted cash of $1,000,000 under a cash use agreement which has been recorded as long-term debt in the consolidated statements of financial position (note 9). Further, Covestro will issue a certificate of reduction of the letter of credit after completion of the performance milestones. The Company will record development revenue in an amount equal to the certificate of reduction in the consolidated statement of loss and comprehensive loss. Further, after the issuance of the certificate of reduction, the letter of credit with TD will decrease for the corresponding amount. As at March 31, 2021, the letter of credit with TD is fully outstanding and no amounts have been drawn by Covestro. |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
| b) | During 2020, the Company signed a three-year supply deal with Covestro Deutschland AG, which provides early access to new photo-sensitive holographic film materials, the building block of META’s holographic product. This agreement will not only allow early access to Covestro’s R&D library of photopolymer films but will also accelerate META’s product development and speed of innovation. Target markets include photonics/optical filters and holographic optical elements, diffusers, laser eye protection, optical combiners, and AR (augmented reality) applications. |
| c) | During 2018, the Company arranged a guarantee/standby letter of credit with RBC in favour of Satair A/S for US $500,000 in relation to an advance payment received. In the event the Company fails to deliver the product as per the contract or refuse to accept the return of the product as per the buyback clause of the contract or fails to repay the advance payment in accordance with the conditions of the agreement signed with Satair on September 18, 2018, Satair shall draw from the letter of credit with RBC. Borrowings from the letter of credit with RBC are repayable on demand. The letter of credit from RBC is secured by a performance security guarantee cover issued by Export Development of Canada. Further, this guarantee/standby letter of credit expires on October 5, 2021. As at March 31, 2021, no amount has been drawn from the letter of credit with RBC. |
| d) | On December 8, 2016, the Company entered into a cooperation agreement with a large aircraft manufacturer to co-develop laser protection filters for space and aeronautical civil and military applications, metaAIR, and support the setup of manufacturing facilities for product certification and development. The cooperation agreement includes financial support provided to the Company in the form of non-recurring engineering costs of up to $4,000,000 USD to be released upon agreement of technical milestones in exchange for a royalty fee due by the Company on gross profit after sales and distribution costs. The total royalty fee to be paid may be adjusted based on the timing of the Company’s sales and the amount ultimately paid to the Company by large aircraft manufacturer to support the development. |
19. Subsequent events
| (a) | On May 11, 2021, the Company received the third and final tranche of ACOA BDP 2019 interest-free loan of $37,835. |
| (b) | Subsequent to March 31, 2021, 117,479 stock options were exercised at $0.62 per share. |
Metamaterial Inc.
Notes to interim condensed consolidated financial statements
For the three months ended March 31, 2021 and 2020
20. Reclassifications and comparative figures
Certain reclassifications have been made to the prior period’s financial statements to enhance comparability with the current period’s financial statements. As a result, certain comparative figures have been adjusted in the interim condensed consolidated statements of loss and comprehensive loss and the interim condensed consolidated statements of cash flows, and the related notes to the interim condensed consolidated financial statements to conform to the current period’s presentation as follows:
| | Three months ended March 31, 2020 | |
| | | Previously | | | | | | | | After | |
| | | reported | | | | Change | | | | reclassification | |
| | | $ | | | | $ | | | | $ | |
| | | | | | | | | | | | |
Interim condensed consolidated statements of loss and comprehensive loss | | | | | | | | | | | | |
Finance income | | | — | | | | (16,350 | ) | | | (16,350 | ) |
Finance costs | | | — | | | | 263,674 | | | | 263,674 | |
Government assistance | | | (61,756 | ) | | | 16,085 | | | | (45,671 | ) |
Interest and bank charges | | | 120,273 | | | | (120,273 | ) | | | — | |
Non-cash interest accretion | | | 143,401 | | | | (143,401 | ) | | | — | |
Interest income | | | (265 | ) | | | 265 | | | | — | |
| | | 201,653 | | | | — | | | | 201,653 | |
| | | | | | | | | | | | |
| | Three months ended March 31, 2020 | |
| | | | | | | | | | | | |
| | Previously | | | | | | | After | |
| | reported | | | Change | | | reclassification | |
| | $ | | | $ | | | $ | |
| | | | | | | | | | | | |
Interim condensed consolidated statements of cash flows | | | | | | | | | | | | |
Non-cash finance income | | | — | | | | (16,085 | ) | | | (16,085 | ) |
Non-cash finance costs | | | — | | | | 225,922 | | | | 225,922 | |
Change in deferred revenue | | | 85,562 | | | | (189,867 | ) | | | (104,305 | ) |
Change in deferred government assistance | | | — | | | | 144,196 | | | | 144,196 | |
Government assistance | | | (61,756 | ) | | | 61,756 | | | | — | |
Non-cash interest accretion | | | 143,521 | | | | (143,521 | ) | | | — | |
Interest expense | | | 82,401 | | | | (82,401 | ) | | | — | |
| | | 249,728 | | | | — | | | | 249,728 | |